Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Impaired Glucose Tolerance In Ischemic Heart Disease
Download Impaired Glucose Tolerance In Ischemic Heart Disease full books in PDF, epub, and Kindle. Read online Impaired Glucose Tolerance In Ischemic Heart Disease ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Impaired Glucose Tolerance in Ischemic Heart Disease by : Loghman Henareh
Download or read book Impaired Glucose Tolerance in Ischemic Heart Disease written by Loghman Henareh and published by . This book was released on 2005 with total page 68 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Medical Management of Diabetes and Heart Disease by : Burton E. Sobel
Download or read book Medical Management of Diabetes and Heart Disease written by Burton E. Sobel and published by CRC Press. This book was released on 2002-03-06 with total page 306 pages. Available in PDF, EPUB and Kindle. Book excerpt: This state-of-the-art reference details current and effective symptom-specific strategies for the diagnosis and management of diabetic patients-emphasizing the exploration of therapeutic options available for the treatment of accelerated coronary complications associated with diabetes. Addresses the pathophysiology underlying advanced heart
Book Synopsis Impaired Glucose Tolerance and Cardiovascular Disease by : Willa A. Hsueh
Download or read book Impaired Glucose Tolerance and Cardiovascular Disease written by Willa A. Hsueh and published by . This book was released on 2006 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Progress in Metabolic Syndrome Research by : George T. Ulrig
Download or read book Progress in Metabolic Syndrome Research written by George T. Ulrig and published by Nova Publishers. This book was released on 2006 with total page 158 pages. Available in PDF, EPUB and Kindle. Book excerpt: Since cardiovascular (heart and blood vessel) disease is the leading cause of death for adults in developed countries, many medical studies focus on treating or preventing heart disease and stroke. The metabolic syndrome, a collection of unhealthy body measurements and abnormal laboratory test results, may identify persons at high risk for developing cardiovascular disease. Aggressive lifestyle modification and possible use of medications to treat the conditions that make up the metabolic syndrome may reduce a person's chances of developing heart disease or stroke. The metabolic syndrome has also been called syndrome X or insulin resistance syndrome.
Download or read book Cardiometabolic Risk written by Prasanna and published by Elsevier India. This book was released on 2009 with total page 120 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Diabetes and Atherosclerosis by : R.W. Stout
Download or read book Diabetes and Atherosclerosis written by R.W. Stout and published by Springer Science & Business Media. This book was released on 2012-12-06 with total page 434 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Contribution of Impaired Glucose Metabolism to Cardiovascular Disease and Mortality in Australians by : Elizabeth Barr
Download or read book The Contribution of Impaired Glucose Metabolism to Cardiovascular Disease and Mortality in Australians written by Elizabeth Barr and published by . This book was released on 2009 with total page 466 pages. Available in PDF, EPUB and Kindle. Book excerpt: Diabetes and cardiovascular disease (CVD) together represent one of the greatest public health and economic burdens for the Australian population. There is strong evidence that diabetes increases the risk of CVD and mortality, and emerging evidence from overseas populations indicates that the risk of CVD and mortality extends below the threshold to diagnose diabetes. By analysing data from the Australian Diabetes, Obesity and Lifestyle (AusDiab) study, this thesis explored the relationships between hyperglycaemia and (i) all-cause mortality, (ii) CVD mortality, and (iii) CVD events, including myocardial infarction, stroke, percutaneous transluminal coronary artery angioplasty and coronary artery bypass surgery, and the extent to which these relationships were independent of other traditional CVD risk factors, including insulin sensitivity. The AusDiab study is a national prospective cohort study of 11,247 men and women aged 25 years and over which incorporated a 75 gm oral glucose tolerance test and three indices of blood glucose: fasting plasma glucose (FPG), two-hour post-load plasma glucose (2hPG) and haemoglobin A1c (HbA1c). The updated homeostasis model assessment was also used to calculate an index of insulin sensitivity (HOMA-%S). Data on all-cause and CVD mortality were obtained through data linkage with the National Death Index, and self-reported non-fatal CVD events were verified through medical record adjudication; the methods of which were validated by linking a cohort of AusDiab participants from Western Australia to the Western Australian Hospital Morbidity Database. Participants were followed for a median of five to six years, and the association between glucose metabolism, analysed as both continuous and categorical variables, and mortality and CVD were analysed with Cox proportional regression. The findings confirmed the strong association between previously diagnosed diabetes and all-cause mortality, CVD mortality and coronary heart disease, which was independent of traditional CVD risk factors. The risk for all-cause mortality and fatal or non-fatal myocardial infarction was also significantly increased among those with intermediate hyperglycaemia, although for CVD mortality, stronger associations were observed for impairments in FPG than 2hPG. In those without diagnosed diabetes, a continuous relationship between 2hPG and HbA1c and both all-cause and CVD mortality was observed. For FPG, the relationships were J-shaped, with the risks being increased at both high and low glucose concentrations. FPG was a better predictor of CVD mortality compared with 2hPG or HbA1c, but none of the glucose measures improved CVD risk prediction above that provided by traditional CVD risk factors. There was a continuous relationship between HOMA-%S and fatal or nonfatal CVD events, but this was mainly explained by its association with high-density lipoprotein cholesterol. FPG, but not HOMA-%S, significantly improved the prediction of CVD beyond that of other risk factors. Finally, a stronger relationship was observed between abnormal glucose metabolism and fatal or non-fatal myocardial infarction than with coronary artery revascularisation or stroke. Taken together, the findings of this thesis indicate that abnormal glucose metabolism, including both diabetes and intermediate hyperglycaemia, play an important role in the development of CVD, and suggest that CVD prevention strategies should not only target diabetes, but all levels of hyperglycaemia.
Book Synopsis The ESC Textbook of Cardiovascular Medicine by : A. John Camm
Download or read book The ESC Textbook of Cardiovascular Medicine written by A. John Camm and published by . This book was released on 2019 with total page 3198 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Honolulu Heart Program by : Abraham Kagan
Download or read book Honolulu Heart Program written by Abraham Kagan and published by CRC Press. This book was released on 1996-08-01 with total page 222 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Director of this study, Abraham Kagan, has comprehensively summarized the design and main finndings of the study in this book. The Honolulu Heart Program compared and contrasted ethnic Japanese men living in different cultural environments--Honolulu and mainland Japan--assessed their relative risk factors. The study supported many of the existing views on risk factors but also showed suprising trends. One of the trends shows moderate alcohol consumption is a preventative factor. In recent years the risk factors for cardiovascular diseases have become common knowledge. The recently completed Honolulu Heart Program is the largest targeted study to evaluate scientifically such risk factors.
Author :Enrique Z. Fisman Publisher :Karger Medical and Scientific Publishers ISBN 13 :380558427X Total Pages :189 pages Book Rating :4.8/5 (55 download)
Book Synopsis Cardiovascular Diabetology by : Enrique Z. Fisman
Download or read book Cardiovascular Diabetology written by Enrique Z. Fisman and published by Karger Medical and Scientific Publishers. This book was released on 2008-01-01 with total page 189 pages. Available in PDF, EPUB and Kindle. Book excerpt: The prevalence of obesity, metabolic syndrome and diabetes - three links of the same 'atherothrombotic chain' - has reached pandemic proportions worldwide. As a result, our civilization is at war against a threatening enemy: cardio-diabetes. Several independent physiological processes underlie the clustering of cardio-diabetes, including central obesity, insulin resistance, dyslipidemia, inflammation, impaired glucose tolerance, and hypertension. Early detection is of overwhelming importance for public health. The complex and intimate relationship between cardiovascular disease and diabetes from basic science to clinical and therapeutic concerns is discussed in this outstanding book. Beginning with molecular, biochemical, inflammatory and cellular aspects, this publication continues with histological and pathophysiological issues, details particular problems in specific metabolic and clinical settings, and finally analyzes several aspects of clinical pharmacology focusing on the optimal management of combined dyslipidemia and non-insulin antidiabetic therapy in cardiac diabetic patients. This book will be a gain in knowledge for every cardiologist, diabetologist, specialist in internal medicine, nutritionalist, general physician and medical student.
Book Synopsis Insulin Resistance - ECAB by : Gita Ganguly Mukherjee
Download or read book Insulin Resistance - ECAB written by Gita Ganguly Mukherjee and published by Elsevier Health Sciences. This book was released on 2012-06-07 with total page 147 pages. Available in PDF, EPUB and Kindle. Book excerpt: The insulin resistance syndrome can be defined as insulin resistance, compensatory hyperinsulinemia, and their associated co-morbidities. Clinically, the term insulin resistance syndrome describes a constellation of abnormalities such as obesity, hypertension, dyslipidemia, type 2 diabetes/hyperglycemia, and coronary artery disease. Insulin is responsible for glucose uptake into the body cells and tissues. The response of the cells to insulin varies from individual to individual. In some individuals, the tissue response to insulin may be diminished. This means that even with adequate levels of insulin, the glucose uptake into the cells and tissues is not optimal. This results in a compensatory over-secretion of insulin from the pancreas. The persistence of high levels of insulin in the blood or hyperinsulinemia is thought to be responsible for some of the abnormalities associated with this condition. However, the exact causal association of the condition with these disorders and the pathophysiology of their evolution are unclear. The most common underlying mechanism proposed is increased free fatty acids from abdominal fat in individuals with central obesity. This leads to deranged insulin signaling, reduced muscular glucose uptake, increased triglyceride synthesis, and hepatic gluconeogenesis. A genetic basis of the disease as well as several other factors such as tumor necrosis factor-α, adiponectin, leptin, Interleukin-6, and some adipokines have also been implicated. Insulin resistance syndrome is of clinical significance because of its association with potentially debilitating conditions that contribute to long-term morbidity and even mortality of the individual. People with insulin resistance syndrome are at an increased risk of developing type 2 diabetes, hypertension, dyslipidemia, myocardial infarction, polycystic ovarian disease, and fatty liver. In this book, we have tried to collate the experiences of the pioneers of this field on the subject and provide the reader a comprehensive view on the topic along with practical management points, which we are sure will benefit the physicians in their clinical practice. The contributors have focused on the condition as is prevalent in our subcontinent and have tried to give an insight on the issues pertaining to the same with a topical flavor.
Book Synopsis Prevalence of Diabetes Mellitus, Impaired Glucose Tolerance and Coronary Heart Disease in Adult Bahraini Natives and Their Risk Factors by : Faisal Jaffar Almahroos
Download or read book Prevalence of Diabetes Mellitus, Impaired Glucose Tolerance and Coronary Heart Disease in Adult Bahraini Natives and Their Risk Factors written by Faisal Jaffar Almahroos and published by . This book was released on 1997 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome by : Ronald A. Codario
Download or read book Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome written by Ronald A. Codario and published by Springer Science & Business Media. This book was released on 2010-11-18 with total page 378 pages. Available in PDF, EPUB and Kindle. Book excerpt: Diagnosing and managing type 2 diabetes presents an enormous challenge to the primary care provider confronted with multiple emerging scientific insights, therapeutic strategies and risk reduction principles. In Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome: The Primary Care Guide to Diagnosis and Management, Second Edition, Ronald A. Codario, M.D., FACP -- a well-known and highly respected authority on diabetes -- details the state-of-the-art in diagnosing, managing and attenuating risks in patients with this disease. Utilizing his extensive experience in private practice, medical education and clinical research for over 35 years, Dr. Codario explains in simple clinical terms, the current understanding of the pathophysiology of diabetes, the latest clinical trials, developing controversies, updates on new medications and an expanded section on Special Populations. With his unique, multiple board certifications in clinical hypertension, vascular medicine, internal medicine, vascular ultrasound and clinical lipidology, Dr. Codario provides practical guidelines for treatment with insulin and oral agents, lipid and hypertension control and comprehensive risk reduction strategies. Extensively reviewed are the metabolic syndrome, the role of exercise and nutrition, and key issues associated with herb and nutriceutical use. Illustrative case studies in diabetes management, an outstanding bibliography of suggested readings, and extensive chapter subheadings for quick reference make this book a practical, easy-to-read guide for dealing with this killer disease. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome: The Primary Care Guide to Diagnosis and Management, Second Edition is the direct result of many years of listening, teaching, lecturing and empathizing with fellow primary care providers and their patients in the ongoing fight against diabetes. Like the internationally acclaimed first edition, this is a must read and invaluable guide for all primary care providers, students, caregivers and patients battling the ravages of this ever increasing epidemic.
Book Synopsis Metabolic Syndrome and Cardiovascular Disease by : Andrew J. Krentz
Download or read book Metabolic Syndrome and Cardiovascular Disease written by Andrew J. Krentz and published by CRC Press. This book was released on 2006-11-08 with total page 340 pages. Available in PDF, EPUB and Kindle. Book excerpt: Addressing a topic of utmost importance in the field, this text addresses the epidemiology, diagnosis, assessment, and management of patients with metabolic syndrome-focusing on implications for cardiovascular disease risk. With an abundance of clearly organized tables, flowcharts, and practice guidelines, this blue-ribbon source succinctly analyze
Book Synopsis Pathophysiology of Cardiovascular Disease by : Naranjan S. Dhalla
Download or read book Pathophysiology of Cardiovascular Disease written by Naranjan S. Dhalla and published by Springer. This book was released on 2012-10-31 with total page 648 pages. Available in PDF, EPUB and Kindle. Book excerpt: Pathophysiology of Cardiovascular Disease has been divided into four sections that focus on heart dysfunction and its associated characteristics (hypertrophy, cardiomyopathy and failure); vascular dysfunction and disease; ischemic heart disease; and novel therapeutic interventions. This volume is a compendium of different approaches to understanding cardiovascular disease and identifying the proteins, pathways and processes that impact it.
Book Synopsis The Diabetic Coronary Patient by : William C. Stanley
Download or read book The Diabetic Coronary Patient written by William C. Stanley and published by . This book was released on 2003 with total page 96 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis The Evidence Base for Diabetes Care by : Rhys Williams
Download or read book The Evidence Base for Diabetes Care written by Rhys Williams and published by John Wiley & Sons. This book was released on 2003-07-11 with total page 796 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume outlines what is meant by terms such as 'evidence based practice', 'systematic review', 'efficacy', 'effectiveness'. It summarises, in a systematic fashion, the current evidence on diabetes prevention and care to enable the reader to improve their professional practice. Furthermore, it promotes a critical attitude to the assessment of evidence and engenders enthusiasm for 'lifelong learning'. It also advises clinicians on what to do when there is little available evidence. Chapters consider the evidence base for the definition and classification of diabetes, as well as prevention, identification, treatment, education in IDDM and NIDDM. The final chapters look at the practical implications of translating this evidence into practice in different environments with different health care systems and different economic levels. This is the first book to present an evidence-based approach to diabetes Examines the evidence base for the definition and classification of diabetes, as well as prevention, iden tification, treatment, and education in IDDM and NIDDM Looks at the practical implications of translating this evidence into practice in different environments The editors are leaders in the move towards evidence-based diabetes care